GPT Healthcare Ltd - 544131 - Intimation Regarding Change Of Corporate Identification Number ('CIN') Of GPT Healthcare Limited ('The Company')
Please find enclosed with a letter intimating change in CIN of the Company.26-04-2024
26-04-2024
GPT Healthcare Ltd - 544131 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find enclosed herewith intimation for investor meet on April 29, 2024.25-04-2024
GPT Healthcare Ltd - 544131 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Please find enclose herewith intimation under regulation 30 of SEBI (LODR) Regulations, 2015.25-04-2024
GPT Healthcare Ltd - 544131 - Compliance Certificate Pursuant To Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2024
Please find enclosed herewith the Compliance Certificate under Reg 7(3) of SEBI(LODR) Regulations, 2015 for the year ended March 31, 2024.24-04-2024
GPT Healthcare Ltd - 544131 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find herewith intimation for Investor meet on April 29, 202424-04-2024
GPT Healthcare Ltd - 544131 - Announcement under Regulation 30 (LODR)-Change in Management
Please find enclosed herewith the intimation under regulation 30 of SEBI(LODR) Regulations, 2015 for resignation of SMP.20-04-2024
GPT Healthcare Ltd - 544131 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyGPT Healthcare Ltd 2CIN NO.U70101WB1989PLC047402 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 10.14 4Highest Credit Rating during the previous FY A- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Ankur Sharma Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Kriti Tantia Designation: Chief Financial Officer EmailId: [email protected] Date: 16/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.16-04-2024
GPT Healthcare Ltd - 544131 - Certificate Pursuant To Regulation 40(9) & (10) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2024
Please find enclosed herewith the Certificate required under Regulation 40(9) & 40(10)of SEBI(LODR) Regulations, 201516-04-2024
GPT Healthcare Ltd - 544131 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith the certificate under regulation 74(5) of SEBI(Depositories and Participants) regulations, 2018 for the quarter ended March 31, 2024.16-04-2024
GPT Healthcare Ltd - 544131 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find enclosed herewith intimation for Investor Meet on April 18, 2024.12-04-2024